Atlas Trials

Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy Using SBRT for Prostate Cancer to Reduce Treatment Toxicity

Clinical trial NCT07515651 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07515651
Sponsor
University Health Network, Toronto
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer (Adenocarcinoma)
Start date
2026-05-01
Primary completion
2034-05-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.